Hiroshima University is a Japanese national university located in Higashihiroshima and Hiroshima, Japan. Established in 1929, it was chartered as a university in 1949 following the merge of a number of national educational institutions.

During the past decade, Hiroshima University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hiroshima University" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hiroshima University" are "Advanced Hepatocellular Carcinoma" (1 trials), "Hepatic Cancer" (1 trials), "Ischemic Stroke" (1 trials), "Liver Cancer" (1 trials) and "Liver Neoplasms" (1 trials). Many other conditions were trialed in "Hiroshima University" in a lesser frequency.

Most popular intervention types in "Hiroshima University" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CS-1008 2 mg/kg" (1 trials), "CS-1008 4 mg/kg" (1 trials), "CS-1008 6 mg/kg" (1 trials), "CS-1008 6/2 mg/kg" (1 trials) and "CS-1008 6/6 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hiroshima University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hiroshima University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hiroshima University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hiroshima University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".